MiR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2
Authors
Affiliations
This study was designed to investigate the precise mechanisms of miR-325-3p/S100A2 axis in breast cancer (BC). In this study, we found that the level of miR-325-3p was dramatically increased in BC tissues and cell lines, and the expression of S100A2 was significantly decreased. Also, the high level of miR-325-3p was closely associated with low expression of S100A2 in BC tissues. Moreover, introduction of miR-325-3p significantly promoted proliferation, invasion, and EMT of BC cells. Bioinformatics analysis predicted that the S100A2 was a potential target gene of miR-325-3p. Luciferase reporter assay demonstrated that miR-325-3p could directly target S100A2. In addition, miR-325-3p overexpression had similar effects with knockdown of S100A2 on BC cells. Overexpression of S100A2 in BC cells partially reversed the promoted effects of miR-325-3p mimic. Overexpression of miR-325-3p promoted cell proliferation, invasion, and EMT of BC cells by directly downregulating S100A2 expression.
Gene expression profiling for the diagnosis of male breast cancer.
Liu J, Sun Y, Qi P, Wo Y, Pang Y, Xu Q BMC Cancer. 2024; 24(1):1584.
PMID: 39731080 PMC: 11681697. DOI: 10.1186/s12885-024-13358-4.
Yang X, Zheng F, Yan P, Liu X, Chen X, Du X Cell Biol Toxicol. 2024; 40(1):86.
PMID: 39382800 PMC: 11464619. DOI: 10.1007/s10565-024-09929-7.
Winkler J, Tan W, Diadhiou C, McGinnis C, Abbasi A, Hasnain S J Clin Invest. 2024; 134(17).
PMID: 39225101 PMC: 11364385. DOI: 10.1172/JCI164227.
TFAP2A Activates S100A2 to Mediate Glutamine Metabolism and Promote Lung Adenocarcinoma Metastasis.
Zeng T, Ren W, Zeng H, Wang D, Wu X, Xu G Clin Respir J. 2024; 18(8):e13825.
PMID: 39187936 PMC: 11347387. DOI: 10.1111/crj.13825.
Fu Z, Zhou Y, Zhang Y, Zhou Z, Yu Y, Yuan C Oncol Lett. 2024; 28(4):459.
PMID: 39119235 PMC: 11307554. DOI: 10.3892/ol.2024.14592.